| Source NDC Code |
|
Target HCPCS Code |
44087-0044-03
REBIF 44 MCG/0.5 ML SYRINGE
|
⇄
|
J1826
Injection, interferon beta-1a, 30 mcg
|
| Detail Information |
| Relationship Start Date |
01/01/2011 |
| Relationship End Date |
12/31/2022 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|
44087-0044-03
REBIF (SRN,PREFILLED,27G,PF) 44 MCG/0.5 ML
|
⇄
|
J3490
UNCLASSIFIED DRUGS
|
| Detail Information |
| Relationship Start Date |
3/13/2002 |
| Relationship End Date |
12/31/2002 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
SC |
| Billing Units |
ML |
|
|
|
44087-0044-03
REBIF (SRN,PREFILLED,27G,PF) 44 MCG/0.5 ML
|
⇄
|
Q3026
INJECTION, INTERFERON BETA-1A, 11 MCG FOR SUBCUTANEOUS USE
|
| Detail Information |
| Relationship Start Date |
1/1/2003 |
| Relationship End Date |
12/31/2013 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SR |
| Route Of Administration |
SC |
| Billing Units |
ML |
|
|
|
44087-0044-03
REBIF 44 MCG/0.5 ML SYRINGE
|
⇄
|
Q3028
Injection, interferon beta-1a, 1 mcg for subcutaneous use
|
| Detail Information |
| Relationship Start Date |
04/15/2018 |
| Relationship End Date |
12/31/3999 |
| Number Of Items In Ndc Package |
0.5 |
| Ndc Package Measure |
ML |
| Ndc Package Type |
SYRINGE |
| Route Of Administration |
SQ |
| Billing Units |
ML |
|
|
|